Search Results | Chinese Journal of Pharmacoepidemiology

Home Results

A total of 8 result was found. Results that relate to Economic

黄葵胶囊对比氯沙坦钾片治疗IgA肾病的药物经济学评价

Liang-Wen GOU Zhao-Ting GUO Qiong LUO Nan YANG Ming HU

DOI：10.19960/j.issn.1005-0698.202301001

Huangkui capsule Losartan potassium tablets Chronic kidney disease Pharmacoeconomics Cost-utility analysis
Details Download Mobile
阿扎胞苷与地西他滨治疗骨髓增生异常综合征的成本-效用分析

La-Ji DANZENG Yong-Gong YANG Si-Liang WANG Meng-Ying LIU

DOI：10.19960/j.issn.1005-0698.202312007

Azacitidine Decitabine Myelodysplastic syndrome Markov model Cost-utility analysis Pharmacoeconomics
Details Download Mobile
百令胶囊联合西医常规治疗糖尿病肾病的药物经济学研究

HE Yumei LI Wei ZHU He HAN Sheng

DOI：10.12173/j.issn.1005-0698.202401013

Bailing capsules Diabetic kidney disease Meta-analysis Cost- effectiveness analysis Pharmacoeconomics
Details Download Mobile
基于Markov模型的胰高血糖素样肽1受体激动剂联合二甲双胍治疗２型糖尿病药物经济学评价

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

DOI：10.12173/j.issn.1005-0698.202304014

Glucagon-like peptide-1 receptor agonist Metformin Type 2 diabetes mellitus Cost-utility Markov model Pharmacoeconomics
Details Download Mobile
氟替美维吸入粉雾剂治疗慢性阻塞性肺疾病的药物经济学评价

DING Xueru LIU Huimin HE Xiaodong LI Hua LI Zhihao

DOI：10.12173/j.issn.1005-0698.202404016

Fluticasone furoate/umeclidinium/vilanterol Chronic obstructive pulmonary disease Markov model Cost-utility analysis Pharmacoeconomic
Details Download Mobile
罗普司亭治疗成人原发免疫性血小板减少症的快速卫生技术评估

LI Jie XIE Jun HAN Yi MENG Ying GAO Liyuan SHI Xiaohui JIANG Zhitao

DOI：10.12173/j.issn.1005-0698.202406058

Romiplostim Primary immune thrombocytopenia Efficacy Safety Economic Rapid health technology assessment
Details Download Mobile
引入公平性信息的卫生经济性评价方法与研究进展

FANG Nan HE Xiaoning WU Jing

DOI：10.12173/j.issn.1005-0698.202406026

Economic evaluation Equity Equity-based weighting Distributional cost-effectiveness Extended cost-effectiveness analysis
Details Download Mobile
帕博利珠单抗联合化疗治疗晚期恶性胸膜间皮瘤的成本-效用分析

HU Yunjia ZOU Keqing HOU Yanhong

DOI：10.12173/j.issn.1005-0698.202407011

Pembrolizumab Chemotherapy Advanced malignant pleural mesothelioma Partitioned survival model Cost-utility analysis Pharmacoeconomic evaluation
Details Download Mobile